Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743194594> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2743194594 abstract "Background and purpose: Nonadherence of antithrombotic medicine is one of major risk factors for recurrent strokes. Immunotherapy, such as antithrombotic vaccination, is expected to solve such a problem due to its long-lasting effects. Here, we focused on platelet-derived S100A9, which has directly regulate thrombosis without influence on hemostasis, and examined the antithrombotic effects of newly developed S100A9 vaccine in mice. Methods: S100A9 vaccine was designed to select the short peptide as an antigen of S100A9 conjugated to keyhole limpet hemocyanin (KLH). Male C57BL/6J mice were immunized with S100A9 vaccine three times at 2 weeks interval. Middle cerebral arteries (MCA) was exposed to topical application of 20% ferric chloride. The time to occlude the MCA was examined measuring cerebral blood flow with a laser doppler flowmeter. Bleeding time was assessed by cutting the tail arteries. The thrombus formation was also assessed using the laminar flow chamber. The influences of vaccine for T-cell activation were assed using an IgG subclass ELISA and an enzyme-linked immunosorbent spot (ELISPOT) assay. Results: S100A9 vaccine successfully produced antibodies specific for S100A9 in serum in a dose-dependent manner. After the third immunization, the time to thrombus formation in MCA was significantly prolonged in the mice vaccinated with S100A9 compared to the non-immunized mice (23.3 ± 4.3 min vs 6.9 ± 0.8 min, p<0.01), but bleeding time was same in both groups. There was no significant difference in platelet count in both groups. The formation of platelet thrombus under ex vivo was significantly reduced in S100A9 vaccine group compared to control group (14.8 ± 0.7 x10 4 /μm 2 vs 17.8 ± 0.9 x10 4 /μm 2 , p<0.05). In the IgG subclass ELISA, the IgG1:IgG2b ratio was greater than 1.0 in the S100A9 vaccine group. In the ELISPOT assay using splenocytes isolated from S100A9 immunized mice, stimulation with S100A9 partial peptide did not induce the production of IFN-gamma and IL-4 in comparison with KLH. Conclusion: The S100A9 vaccine could successfully prevent thrombus formation in MCA without influence on hemostasis nor eliciting an autoimmune response. S100A9 vaccine might shed light on the development of safe antithrombotic vaccine in ischemic stroke." @default.
- W2743194594 created "2017-08-17" @default.
- W2743194594 creator A5019618077 @default.
- W2743194594 creator A5025005882 @default.
- W2743194594 creator A5043476878 @default.
- W2743194594 creator A5044022978 @default.
- W2743194594 creator A5059619179 @default.
- W2743194594 creator A5064235843 @default.
- W2743194594 creator A5070119712 @default.
- W2743194594 creator A5072665941 @default.
- W2743194594 date "2017-02-01" @default.
- W2743194594 modified "2023-09-23" @default.
- W2743194594 title "Abstract 145: Development of Novel S100A9 Peptide Vaccine for Prevention of Thrombus Formation in Ischemic Stroke in Mice" @default.
- W2743194594 doi "https://doi.org/10.1161/str.48.suppl_1.145" @default.
- W2743194594 hasPublicationYear "2017" @default.
- W2743194594 type Work @default.
- W2743194594 sameAs 2743194594 @default.
- W2743194594 citedByCount "0" @default.
- W2743194594 crossrefType "journal-article" @default.
- W2743194594 hasAuthorship W2743194594A5019618077 @default.
- W2743194594 hasAuthorship W2743194594A5025005882 @default.
- W2743194594 hasAuthorship W2743194594A5043476878 @default.
- W2743194594 hasAuthorship W2743194594A5044022978 @default.
- W2743194594 hasAuthorship W2743194594A5059619179 @default.
- W2743194594 hasAuthorship W2743194594A5064235843 @default.
- W2743194594 hasAuthorship W2743194594A5070119712 @default.
- W2743194594 hasAuthorship W2743194594A5072665941 @default.
- W2743194594 hasConcept C126322002 @default.
- W2743194594 hasConcept C127413603 @default.
- W2743194594 hasConcept C141071460 @default.
- W2743194594 hasConcept C203014093 @default.
- W2743194594 hasConcept C22070199 @default.
- W2743194594 hasConcept C2776090121 @default.
- W2743194594 hasConcept C2777015399 @default.
- W2743194594 hasConcept C2778589496 @default.
- W2743194594 hasConcept C2779053233 @default.
- W2743194594 hasConcept C2780645631 @default.
- W2743194594 hasConcept C2780868729 @default.
- W2743194594 hasConcept C2781362458 @default.
- W2743194594 hasConcept C3018697912 @default.
- W2743194594 hasConcept C71924100 @default.
- W2743194594 hasConcept C78519656 @default.
- W2743194594 hasConcept C8891405 @default.
- W2743194594 hasConcept C89560881 @default.
- W2743194594 hasConcept C90924648 @default.
- W2743194594 hasConceptScore W2743194594C126322002 @default.
- W2743194594 hasConceptScore W2743194594C127413603 @default.
- W2743194594 hasConceptScore W2743194594C141071460 @default.
- W2743194594 hasConceptScore W2743194594C203014093 @default.
- W2743194594 hasConceptScore W2743194594C22070199 @default.
- W2743194594 hasConceptScore W2743194594C2776090121 @default.
- W2743194594 hasConceptScore W2743194594C2777015399 @default.
- W2743194594 hasConceptScore W2743194594C2778589496 @default.
- W2743194594 hasConceptScore W2743194594C2779053233 @default.
- W2743194594 hasConceptScore W2743194594C2780645631 @default.
- W2743194594 hasConceptScore W2743194594C2780868729 @default.
- W2743194594 hasConceptScore W2743194594C2781362458 @default.
- W2743194594 hasConceptScore W2743194594C3018697912 @default.
- W2743194594 hasConceptScore W2743194594C71924100 @default.
- W2743194594 hasConceptScore W2743194594C78519656 @default.
- W2743194594 hasConceptScore W2743194594C8891405 @default.
- W2743194594 hasConceptScore W2743194594C89560881 @default.
- W2743194594 hasConceptScore W2743194594C90924648 @default.
- W2743194594 hasIssue "suppl_1" @default.
- W2743194594 hasLocation W27431945941 @default.
- W2743194594 hasOpenAccess W2743194594 @default.
- W2743194594 hasPrimaryLocation W27431945941 @default.
- W2743194594 hasRelatedWork W194213243 @default.
- W2743194594 hasRelatedWork W1964839555 @default.
- W2743194594 hasRelatedWork W1978375825 @default.
- W2743194594 hasRelatedWork W2170897550 @default.
- W2743194594 hasRelatedWork W2344036867 @default.
- W2743194594 hasRelatedWork W2434105999 @default.
- W2743194594 hasRelatedWork W2963446855 @default.
- W2743194594 hasRelatedWork W2971414298 @default.
- W2743194594 hasRelatedWork W4282980220 @default.
- W2743194594 hasRelatedWork W52452193 @default.
- W2743194594 hasVolume "48" @default.
- W2743194594 isParatext "false" @default.
- W2743194594 isRetracted "false" @default.
- W2743194594 magId "2743194594" @default.
- W2743194594 workType "article" @default.